24HourWire
News from all angles
MedPage Today
Center
New Trials Back Quickly Approved Drugs for Primary Biliary Cholangitis
(MedPage Today) -- Treatment with both elafibranor (Iqirvo) and seladelpar (Livdelzi) led to alkaline phosphatase (ALP) normalization in the vast majority of patients with primary biliary cholangitis…